1. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
Yu L, Wang L, Chen S.
Neoplasma. 2011;58(1):9-13. Review.
PMID:21067260[PubMed - indexed for MEDLINE]
2. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, Palanisamy N, Voorhoeve PM, Tan P.
Clin Cancer Res. 2011 May 1;17(9):2657-67. Epub 2011 Mar 17.
PMID:21415212[PubMed - in process]
3. Olfactomedin 4 is a marker for progression of cervical neoplasia. Yu L, He M, Yang Z, Chen G, Li M, Wang L, Chen S.
Int J Gynecol Cancer. 2011 Feb;21(2):367-72.
PMID:21270618[PubMed - indexed for MEDLINE]
4. Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.
Dassen H, Punyadeera C, Delvoux B, Schulkens I, Marchetti C, Kamps R, Klomp J, Dijcks F, de Goeij A, D'Hooghe T, Kyama C, Ederveen A, Dunselman G, Groothuis P, Romano A.
Am J Pathol. 2010 Nov;177(5):2495-508.
PMID:21048224[PubMed - indexed for MEDLINE]
